SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020490
Filing Date
2018-08-08
Accepted
2018-08-08 16:17:04
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q drna-10q_20180630.htm 10-Q 1592325
2 EX-10.1 drna-ex101_125.htm EX-10.1 156880
3 EX-10.2 drna-ex102_180.htm EX-10.2 81432
4 EX-31.1 drna-ex311_8.htm EX-31.1 8060
5 EX-31.2 drna-ex312_7.htm EX-31.2 8056
6 EX-32.1 drna-ex321_6.htm EX-32.1 7424
7 GRAPHIC gqleeib21isi000001.jpg GRAPHIC 30333
  Complete submission text file 0001564590-18-020490.txt   4621450

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT drna-20180630.xml EX-101.INS 800966
9 XBRL TAXONOMY EXTENSION SCHEMA drna-20180630.xsd EX-101.SCH 31926
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20180630_cal.xml EX-101.CAL 37329
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20180630_def.xml EX-101.DEF 77794
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20180630_lab.xml EX-101.LAB 224279
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20180630_pre.xml EX-101.PRE 170658
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 181001571
SIC: 2834 Pharmaceutical Preparations